{"gene":"CRP","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1977,"finding":"Human C-reactive protein and the complement subcomponent C1t are structurally homologous proteins (pentraxins) composed of five subunits arranged in cyclic pentameric symmetry, as revealed by partial amino acid sequencing and negative-stain electron microscopy.","method":"Amino acid sequencing and negative-stain electron microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct structural characterization by sequencing and EM, foundational discovery replicated extensively","pmids":["265538"],"is_preprint":false},{"year":1989,"finding":"Human CRP binds to the basement membrane protein laminin in vitro in a Ca2+-dependent manner via its phosphocholine (PC) binding site, providing a mechanism for selective CRP deposition at inflamed sites. The binding requires Ca2+-induced conformational change in CRP and was inhibitable by soluble PC and anti-PC-site monoclonal antibodies.","method":"In vitro binding assay with radiolabeled CRP, inhibition by soluble PC and anti-idiotypic mAbs directed to PC-binding site","journal":"Journal of cellular biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with ligand competition and site-specific antibody inhibition","pmids":["2745572"],"is_preprint":false},{"year":1993,"finding":"Mouse CRP (moCRP) gene expression is tissue-specific to liver and induced by IL-1 but not IL-6 in isolated hepatocytes, contrasting with human CRP where IL-6 is the dominant inducer. IL-1 may act post-transcriptionally rather than transcriptionally on the moCRP gene.","method":"Isolated mouse hepatocyte culture, cytokine stimulation, gene expression analysis, CAT reporter transfection","journal":"Cytokine","confidence":"Medium","confidence_rationale":"Tier 2 — functional cell-based assay with cytokine dissection and reporter assay, single study","pmids":["8260597"],"is_preprint":false},{"year":1996,"finding":"The three-dimensional crystal structure of human CRP reveals that phosphocholine binding is mediated through calcium ions and a hydrophobic pocket centered on Phe66, with Glu81 positioned to interact with the choline group. A cleft on the pentameric face opposite the calcium site may have an important functional role.","method":"X-ray crystallography","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional site identification","pmids":["8599761"],"is_preprint":false},{"year":1986,"finding":"CRP-pneumococcal C-polysaccharide (CPS) complexes are taken up by neutrophils via a specific CRP-dependent mechanism that promotes CPS clearance, further enhanced by complement activation. Physiological concentrations of low-density lipoprotein inhibit entry of complexed CPS but not CRP alone into neutrophils. Pure CRP has no effect on neutrophil chemotaxis or oxidative metabolism.","method":"Neutrophil uptake assays, complement activation, LDL inhibition experiments","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional assay with defined ligand/receptor interactions, single study","pmids":["3708910"],"is_preprint":false},{"year":1983,"finding":"Human CRP modulates human B cell colony formation stimulated by Staphylococcal protein A: CRP at 10–25 µg/mL augments colony numbers at early stages, while higher concentrations cause focal disintegration of colony clusters at later stages. CRP-binding cells were detectable by flow cytometry after pre-incubation.","method":"Semisolid B cell colony assay, flow cytometry","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 — functional cell-based assay with clear dose-response and kinetic analysis, single study","pmids":["6600182"],"is_preprint":false},{"year":2006,"finding":"CRP-induced classical complement activation on solid-phase phosphocholine-containing surfaces is efficiently down-regulated at CRP concentrations >150 mg/L, through fluid-phase CRP-C1q interaction that competitively inhibits solid-phase complement activation. This constitutes a self-limiting mechanism of complement regulation.","method":"Ellipsometry measuring protein deposition on PC-KLH surfaces, radial immunodiffusion for CRP-C1q fluid-phase interaction","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct biophysical measurement of complement activation with mechanistic inhibition demonstrated","pmids":["17113035"],"is_preprint":false},{"year":2008,"finding":"CRP induces secretion of chemokines CCL2, CCL3, and CCL4 from human adherent monocytes through binding to Fcγ receptors CD32a, CD32b, and CD64. This is accompanied by CRP-induced upregulation of Mac-1 (CD11b) and ICAM-1 on adherent monocytes, and blockade of Mac-1/ICAM-1 interaction inhibits the CRP-induced chemokine secretion. CRP also reduces surface expression of chemokine receptors CCR1, CCR2, and CCR5 as a consequence of chemokine secretion.","method":"ELISA, flow cytometry, real-time RT-PCR, Boyden chamber migration assay, blocking antibodies","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with receptor blockade mechanistic dissection","pmids":["18591415"],"is_preprint":false},{"year":2009,"finding":"Proinflammatory cytokines IL-1, IL-6, and IL-17 induce CRP production in the liver by signaling through their receptors on hepatic cells, activating kinases and phosphatases that lead to translocation of transcription factors to the CRP gene promoter.","method":"Review synthesizing molecular signaling studies in hepatic cells","journal":"Advances in clinical chemistry","confidence":"Low","confidence_rationale":"Tier 4 — review/synthesis paper, no direct new experimental data","pmids":["19803417"],"is_preprint":false},{"year":2011,"finding":"Fcγ receptors (FcγRs) serve as the primary receptors for pentraxins CRP and SAP, mediating their opsonic functions and clearance of apoptotic cells. The crystal structure of SAP in complex with FcγRIIa was solved, revealing structural basis for pentraxin-receptor interaction relevant to CRP function.","method":"Crystal structure of SAP-FcγRIIa complex, functional studies of Fcγ receptor-mediated clearance","journal":"Current opinion in organ transplantation","confidence":"Medium","confidence_rationale":"Tier 1 for SAP/Tier 3 for CRP inference — crystal structure for SAP provides structural framework for CRP Fcγ receptor interaction","pmids":["21150611"],"is_preprint":false},{"year":2011,"finding":"CRP bound to the surface of secondary necrotic cells (SNEC) serves as a target for anti-CRP autoantibodies. The ternary complex of CRP, anti-CRP autoantibodies, and SNEC is cleared by macrophages in vitro and induces a pro-inflammatory cytokine response, switching phagocytic clearance toward inflammation.","method":"In vitro macrophage phagocytosis assay, cytokine measurement by ELISA","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional in vitro assay with defined molecular components, single study","pmids":["22566859"],"is_preprint":false},{"year":2011,"finding":"CRP directly binds leptin in extracellular settings, impairing leptin's biological actions and contributing to leptin resistance. In vitro, leptin promotes CRP production from hepatocytes and endothelial cells.","method":"In vitro binding assays, hepatocyte and endothelial cell culture experiments","journal":"Current pharmaceutical design","confidence":"Low","confidence_rationale":"Tier 3 — based on a review summarizing binding studies; limited mechanistic detail provided","pmids":["23688010"],"is_preprint":false},{"year":2011,"finding":"Sirt1 physically interacts with HNF-1α in vitro and in vivo under nutrient-restricting conditions to suppress HNF-1α transcriptional activity and the expression of its target gene Crp in mouse primary hepatocytes. Sirt1 and HNF-1α co-localize on two HNF-1α binding sites on the Crp promoter, leading to decreased acetylation of histone H4 lysine 16 at these sites specifically under nutrient restriction. Pharmacological inhibition of Sirt1 blocks nutrient restriction-mediated Crp suppression.","method":"Co-immunoprecipitation, ChIP assay, primary hepatocyte culture, pharmacological Sirt1 inhibition, histone acetylation analysis","journal":"Aging cell","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal interaction demonstrated in vitro and in vivo with ChIP, histone modification, and pharmacological validation; multiple orthogonal methods","pmids":["21176092"],"is_preprint":false},{"year":2011,"finding":"An RNA aptamer binds specifically to monomeric CRP (mCRP) but not to pentameric CRP (pCRP), enabling discrimination between the two isoforms. Monomeric CRP prepared from heated pCRP shows biological activity confirmed by binding to complement protein C1q.","method":"Fluorescence anisotropy aptamer binding assay, gel electrophoresis, TIRF microscopy, C1q binding confirmation","journal":"Analytical and bioanalytical chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay distinguishing isoforms with functional validation of mCRP activity","pmids":["21725632"],"is_preprint":false},{"year":2018,"finding":"CRP induces GDF15 expression in human aortic endothelial cells (HAECs) through p53. CRP treatment or CRP plasmid transfection into HAECs increases GDF15 promoter activity (confirmed by dual-luciferase reporter assay), and ChIP assays confirm that p53 is recruited to both p53 binding sites in the GDF15 promoter in response to CRP.","method":"In vitro CRP treatment, CRP plasmid transfection, dual-luciferase reporter assay, ChIP assay","journal":"Mediators of inflammation","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and reporter assay establish p53 recruitment to GDF15 promoter downstream of CRP, single study","pmids":["29967567"],"is_preprint":false},{"year":2019,"finding":"In pancreatic neuroendocrine neoplasm cells (BON1), CRP stimulation increases IL-6 secretion and invasion, accompanied by activation/phosphorylation of ERK, AKT, and STAT3 pathways. IL-6 exposure upregulates CRP expression and secretion in these cells. CRP is taken up by pNEN cells despite absence of classical CRP receptors CD16, CD32, and CD64.","method":"ELISA, Western blot, flow cytometry, immunocytochemistry, invasion and proliferation assays","journal":"Endocrine connections","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal functional assays with pathway analysis in human cell lines, single study","pmids":["31234146"],"is_preprint":false},{"year":2019,"finding":"Leflunomide inhibits hepatic CRP production through an AHR-ARNT interaction pathway. In CRPH (high CRP) arthritic rats, elevated CRP upregulates HIF1α, which competitively displaces AHR from ARNT association, thereby blocking Leflunomide-AHR-CRP signaling. Hepatocyte-specific HIF1α deletion or pharmacological HIF1α inhibition (acriflavine) restores AHR-ARNT interaction and CRP suppression.","method":"In vivo rat arthritis model, hepatocyte-specific gene deletion, co-immunoprecipitation of AHR-ARNT, pharmacological HIF1α inhibition, serum CRP measurement","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic and pharmacological epistasis in vivo with Co-IP demonstrating competitive mechanism, multiple orthogonal approaches","pmids":["31594926"],"is_preprint":false},{"year":2019,"finding":"Ruxolitinib (JAK1/2 inhibitor) potently represses CRP secretion and mRNA expression in inflammatory human hepatocytes (primary hepatocytes and HepaRG cells) induced by LPS, Toll-like receptor agonists, or pro-inflammatory cytokines (IL-1β, IL-6, TNFα). The mechanism involves blocking the IL-6/JAK/STAT signaling cascade; anti-IL-6 receptor antibody tocilizumab similarly prevents CRP induction, placing JAK/STAT downstream of IL-6 receptor in CRP regulation.","method":"Primary human hepatocyte and HepaRG cell culture, ruxolitinib and tocilizumab pharmacological inhibition, CRP mRNA and protein measurement","journal":"Inflammation research","confidence":"High","confidence_rationale":"Tier 2 — pharmacological dissection with orthogonal pathway inhibitors in human primary cells establishes IL6/JAK/STAT as the mechanistic pathway for CRP induction","pmids":["31654094"],"is_preprint":false}],"current_model":"Human CRP is a pentameric acute-phase protein (pentraxin) whose subunits bind phosphocholine-containing ligands via Ca2+-dependent interaction at a hydrophobic pocket centered on Phe66/Glu81; CRP is produced primarily in the liver under control of IL-6/JAK/STAT and IL-1 signaling (with HNF-1α and Sirt1 as nutrient-sensitive transcriptional regulators), circulates as a pentamer that activates complement via C1q and is opsonized through Fcγ receptors, undergoes conformational conversion to a monomeric form (mCRP) with distinct biological activities including C1q binding and pro-inflammatory signaling, and in vascular and immune cells activates ERK/AKT/STAT3 pathways, induces chemokine secretion via Mac-1/ICAM-1, and regulates downstream genes (e.g., GDF15) through p53 recruitment."},"narrative":{"teleology":[{"year":1977,"claim":"Establishing the pentameric architecture of CRP resolved its quaternary structure and placed it in the pentraxin superfamily alongside complement C1t, providing the structural framework for all subsequent functional studies.","evidence":"Amino acid sequencing and negative-stain electron microscopy of purified human CRP","pmids":["265538"],"confidence":"High","gaps":["Atomic-resolution structure not yet available","Ligand-binding site unidentified at this resolution"]},{"year":1986,"claim":"Demonstrating that CRP–C-polysaccharide complexes are taken up by neutrophils in a complement-enhanced manner established CRP as a functional opsonin, linking ligand recognition to phagocytic clearance.","evidence":"Neutrophil uptake assays with CRP–CPS complexes, complement activation, and LDL inhibition experiments","pmids":["3708910"],"confidence":"Medium","gaps":["Specific neutrophil receptor for CRP not identified","In vivo relevance of LDL inhibition of CRP uptake not tested"]},{"year":1989,"claim":"Showing that CRP binds laminin through its phosphocholine-binding site in a Ca²⁺-dependent manner extended CRP's ligand repertoire beyond microbial polysaccharides to extracellular matrix components at inflamed sites.","evidence":"Radiolabeled CRP binding assays with laminin, inhibited by soluble phosphocholine and anti-PC-site monoclonal antibodies","pmids":["2745572"],"confidence":"High","gaps":["Structural basis of laminin recognition not resolved","Functional consequence of CRP–laminin interaction in tissue inflammation not demonstrated in vivo"]},{"year":1996,"claim":"The crystal structure of human CRP revealed the atomic basis of phosphocholine recognition — Ca²⁺ ions and a hydrophobic pocket centered on Phe66 with Glu81 contacting choline — answering how CRP discriminates its primary ligand.","evidence":"X-ray crystallography of human CRP","pmids":["8599761"],"confidence":"High","gaps":["Functional role of the cleft on the opposite pentameric face undefined","No co-crystal with C1q or Fcγ receptor available"]},{"year":2006,"claim":"Discovery that fluid-phase CRP at high concentrations competitively inhibits solid-phase C1q-mediated complement activation revealed a self-limiting mechanism preventing excessive complement damage during severe inflammation.","evidence":"Ellipsometry on PC-KLH surfaces measuring complement protein deposition at varying CRP concentrations","pmids":["17113035"],"confidence":"Medium","gaps":["In vivo validation of the self-limiting threshold not performed","Structural basis for differential C1q engagement by soluble versus surface-bound CRP unknown"]},{"year":2008,"claim":"Identification of Fcγ receptors CD32a, CD32b, and CD64 as CRP receptors on monocytes, with downstream Mac-1/ICAM-1-dependent chemokine secretion, defined the molecular pathway by which CRP orchestrates innate immune cell recruitment.","evidence":"ELISA, flow cytometry, RT-PCR, Boyden chamber migration, and blocking antibodies in human adherent monocytes","pmids":["18591415"],"confidence":"High","gaps":["Signaling intermediates between Fcγ receptor engagement and Mac-1 upregulation not mapped","Contribution of each individual Fcγ receptor isoform not isolated"]},{"year":2011,"claim":"Multiple studies in 2011 established that CRP exists in functionally distinct pentameric and monomeric isoforms (mCRP retains C1q binding), that CRP opsonizes secondary necrotic cells to switch macrophage clearance toward pro-inflammatory cytokine production, and that Sirt1 suppresses CRP transcription by deacetylating H4K16 at HNF-1α sites on the CRP promoter under nutrient restriction.","evidence":"Aptamer-based isoform discrimination with C1q binding (mCRP); macrophage phagocytosis assay with CRP-opsonized SNEC (clearance); Co-IP, ChIP, and pharmacological Sirt1 inhibition in primary hepatocytes (transcription)","pmids":["21725632","22566859","21176092"],"confidence":"High","gaps":["In vivo sites and triggers of pentamer-to-monomer conversion not defined","Relative contribution of Sirt1 versus other HNF-1α co-regulators in human hepatocytes not established","Receptor(s) mediating mCRP-specific pro-inflammatory signaling unidentified"]},{"year":2018,"claim":"Demonstrating that CRP induces GDF15 expression through p53 recruitment to the GDF15 promoter in aortic endothelial cells linked CRP to a defined transcriptional output in the vasculature.","evidence":"CRP treatment and plasmid transfection in HAECs, dual-luciferase reporter and ChIP assays for p53 at GDF15 promoter","pmids":["29967567"],"confidence":"Medium","gaps":["Upstream mechanism by which CRP activates p53 not determined","Functional consequence of CRP-induced GDF15 on vascular biology not shown","Single study without independent replication"]},{"year":2019,"claim":"Pharmacological dissection using ruxolitinib and tocilizumab in human primary hepatocytes definitively placed IL-6/JAK/STAT as the dominant signaling axis for CRP induction, while a parallel study showed that HIF-1α competes with AHR for ARNT binding to modulate CRP transcription in arthritis, adding an alternative transcriptional regulatory node.","evidence":"Ruxolitinib/tocilizumab in primary hepatocytes and HepaRG cells (JAK/STAT); hepatocyte-specific HIF-1α deletion and Co-IP of AHR-ARNT in arthritic rats (HIF-1α/AHR)","pmids":["31654094","31594926"],"confidence":"High","gaps":["Integration of JAK/STAT, HNF-1α/Sirt1, and AHR/HIF-1α pathways in a unified transcriptional model not achieved","Whether HIF-1α/AHR competition operates in human hepatocytes not confirmed"]},{"year":2019,"claim":"CRP activates ERK, AKT, and STAT3 in pancreatic neuroendocrine neoplasm cells and induces IL-6 secretion and invasion independently of classical Fcγ receptors, suggesting additional CRP uptake mechanisms in non-immune cells.","evidence":"ELISA, Western blot, flow cytometry, and invasion assays in BON1 cells lacking CD16/CD32/CD64","pmids":["31234146"],"confidence":"Medium","gaps":["Alternative receptor or uptake mechanism for CRP in Fcγ receptor-negative cells not identified","In vivo relevance to neuroendocrine tumor progression not established"]},{"year":null,"claim":"Key unresolved questions include the structural basis for CRP–Fcγ receptor and CRP–C1q interactions, the physiological triggers and sites of pentamer-to-monomer conversion in vivo, integration of the multiple transcriptional regulatory inputs (IL-6/JAK/STAT, HNF-1α/Sirt1, AHR/ARNT/HIF-1α) into a unified model, and the identity of the CRP receptor(s) on Fcγ-negative cells.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal structure of CRP with C1q or any Fcγ receptor","In vivo mechanism and kinetics of mCRP generation unknown","Receptor mediating CRP effects in Fcγ receptor-negative cells unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[7,9,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,10,14]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,3,6,13]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,7,9,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,15,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[12,16,17]}],"complexes":[],"partners":["C1Q","FCGR2A","FCGR2B","FCGR1A","SIRT1","HNF1A","ITGAM"],"other_free_text":[]},"mechanistic_narrative":"CRP is a liver-derived pentameric acute-phase pentraxin that recognizes phosphocholine-containing ligands through a Ca²⁺-dependent hydrophobic pocket centered on Phe66 and Glu81, enabling opsonization of pathogens and damaged cells and activation of the classical complement pathway via C1q [PMID:265538, PMID:8599761, PMID:17113035]. Hepatic CRP transcription is driven principally by IL-6/JAK/STAT signaling, with contributions from IL-1 and IL-17, and is negatively regulated by Sirt1-mediated deacetylation of histone H4K16 at HNF-1α-occupied promoter sites under nutrient restriction [PMID:31654094, PMID:21176092]. CRP engages Fcγ receptors on monocytes and neutrophils to promote phagocytic clearance and chemokine secretion (CCL2, CCL3, CCL4) through Mac-1/ICAM-1-dependent signaling, and in vascular and neoplastic cells activates ERK, AKT, and STAT3 pathways that induce IL-6 secretion and p53-dependent GDF15 expression [PMID:18591415, PMID:31234146, PMID:29967567]. Pentameric CRP can undergo conformational dissociation to a monomeric form (mCRP) that retains C1q binding but exhibits distinct biological activities [PMID:21725632]."},"prefetch_data":{"uniprot":{"accession":"P02741","full_name":"C-reactive protein","aliases":[],"length_aa":224,"mass_kda":25.0,"function":"Displays several functions associated with host defense: it promotes agglutination, bacterial capsular swelling, phagocytosis and complement fixation through its calcium-dependent binding to phosphorylcholine. Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P02741/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CRP","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CRP","total_profiled":1310},"omim":[{"mim_id":"621551","title":"TRANSMEMBRANE PROTEIN 39B; TMEM39B","url":"https://www.omim.org/entry/621551"},{"mim_id":"621409","title":"AUTOINFLAMMATION AND AUTOIMMUNITY, SYSTEMIC, WITH IMMUNE DYSREGULATION 2; AIAISD2","url":"https://www.omim.org/entry/621409"},{"mim_id":"621216","title":"PLAQUE-ENRICHED LONG NONCODING RNA IN ATHEROSCLEROTIC AND INFLAMMATORY BOWEL MACROPHAGE REGULATION; PELATON","url":"https://www.omim.org/entry/621216"},{"mim_id":"621140","title":"CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1EE WITH OR WITHOUT IMMUNODEFICIENCY; CDG1EE","url":"https://www.omim.org/entry/621140"},{"mim_id":"621030","title":"AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME, AUTOSOMAL DOMINANT; AIPDSA","url":"https://www.omim.org/entry/621030"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"},{"location":"Intermediate filaments","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":8524.7}],"url":"https://www.proteinatlas.org/search/CRP"},"hgnc":{"alias_symbol":["PTX1"],"prev_symbol":[]},"alphafold":{"accession":"P02741","domains":[{"cath_id":"2.60.120.200","chopping":"26-221","consensus_level":"high","plddt":98.1506,"start":26,"end":221}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02741","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02741-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02741-F1-predicted_aligned_error_v6.png","plddt_mean":94.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CRP","jax_strain_url":"https://www.jax.org/strain/search?query=CRP"},"sequence":{"accession":"P02741","fasta_url":"https://rest.uniprot.org/uniprotkb/P02741.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02741/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02741"}},"corpus_meta":[{"pmid":"29895893","id":"PMC_29895893","title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","date":"2018","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29895893","citation_count":344,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8675014","id":"PMC_8675014","title":"Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8675014","citation_count":337,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10462277","id":"PMC_10462277","title":"Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients.","date":"1999","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/10462277","citation_count":252,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10101115","id":"PMC_10101115","title":"Hindlimb patterning and mandible development require the Ptx1 gene.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10101115","citation_count":234,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16939632","id":"PMC_16939632","title":"C-reactive protein (CRP)-lowering agents.","date":"2006","source":"Cardiovascular drug reviews","url":"https://pubmed.ncbi.nlm.nih.gov/16939632","citation_count":219,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28257825","id":"PMC_28257825","title":"Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.","date":"2017","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/28257825","citation_count":209,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17348038","id":"PMC_17348038","title":"S100B in neuropathologic states: the CRP of the brain?","date":"2007","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/17348038","citation_count":201,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19803417","id":"PMC_19803417","title":"Proinflammatory cytokines in CRP baseline regulation.","date":"2009","source":"Advances in clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19803417","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9226452","id":"PMC_9226452","title":"The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm.","date":"1997","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9226452","citation_count":186,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3623221","id":"PMC_3623221","title":"C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis.","date":"1987","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/3623221","citation_count":154,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11407111","id":"PMC_11407111","title":"Functional versatility in the CRP-FNR superfamily of transcription factors: FNR and FLP.","date":"2001","source":"Advances in microbial physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11407111","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"395815","id":"PMC_395815","title":"C-reactive protein (CRP) in early diagnosis of neonatal septicemia.","date":"1979","source":"Acta paediatrica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/395815","citation_count":127,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15454657","id":"PMC_15454657","title":"Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study.","date":"2004","source":"Thorax","url":"https://pubmed.ncbi.nlm.nih.gov/15454657","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"164435","id":"PMC_164435","title":"Deletion of the Escherichia coli crp gene.","date":"1975","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/164435","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22459389","id":"PMC_22459389","title":"CRP and suPAR are differently related to anthropometry and subclinical organ damage.","date":"2012","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/22459389","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25177663","id":"PMC_25177663","title":"C-Reactive Protein (CRP) and its Association with Periodontal Disease: A Brief Review.","date":"2014","source":"Journal of clinical and diagnostic research : JCDR","url":"https://pubmed.ncbi.nlm.nih.gov/25177663","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17654065","id":"PMC_17654065","title":"ESR or CRP? A comparison of their clinical utility.","date":"2007","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/17654065","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10067870","id":"PMC_10067870","title":"Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development.","date":"1999","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10067870","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15829284","id":"PMC_15829284","title":"CRP after 2004.","date":"2004","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15829284","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19695857","id":"PMC_19695857","title":"Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?","date":"2009","source":"Nutrition, metabolism, and cardiovascular diseases : NMCD","url":"https://pubmed.ncbi.nlm.nih.gov/19695857","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18034890","id":"PMC_18034890","title":"Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults.","date":"2007","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18034890","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10859489","id":"PMC_10859489","title":"Transcriptional properties of Ptx1 and Ptx2 isoforms.","date":"2000","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10859489","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25495587","id":"PMC_25495587","title":"Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder.","date":"2014","source":"Nordic journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25495587","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20034371","id":"PMC_20034371","title":"The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings.","date":"2010","source":"Current diabetes reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20034371","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27594414","id":"PMC_27594414","title":"C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection.","date":"2016","source":"European journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27594414","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9737658","id":"PMC_9737658","title":"Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.","date":"1998","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9737658","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25816203","id":"PMC_25816203","title":"Transcriptomic profiling of Yersinia pseudotuberculosis reveals reprogramming of the Crp regulon by temperature and uncovers Crp as a master regulator of small RNAs.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25816203","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29428699","id":"PMC_29428699","title":"C-reactive protein (CRP) and long-term air pollution with a focus on ultrafine particles.","date":"2018","source":"International journal of hygiene and environmental health","url":"https://pubmed.ncbi.nlm.nih.gov/29428699","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23688010","id":"PMC_23688010","title":"Role of C reactive protein (CRP) in leptin resistance.","date":"2014","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/23688010","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8913296","id":"PMC_8913296","title":"Regulation of HU alpha and HU beta by CRP and FIS in Escherichia coli.","date":"1996","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8913296","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9582281","id":"PMC_9582281","title":"Regulation of crp transcription by oscillation between distinct nucleoprotein complexes.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9582281","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27437213","id":"PMC_27437213","title":"Evaluation of IL-6, CRP and hs-CRP as Early Markers of Neonatal Sepsis.","date":"2016","source":"Journal of clinical and diagnostic research : JCDR","url":"https://pubmed.ncbi.nlm.nih.gov/27437213","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9431811","id":"PMC_9431811","title":"Embryonic expression and characterization of a Ptx1 homolog in Drosophila.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9431811","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21150611","id":"PMC_21150611","title":"Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.","date":"2011","source":"Current opinion in organ transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/21150611","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18591415","id":"PMC_18591415","title":"C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes.","date":"2008","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/18591415","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11279109","id":"PMC_11279109","title":"CRP modulates fis transcription by alternate formation of activating and repressing nucleoprotein complexes.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11279109","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19703305","id":"PMC_19703305","title":"Transcriptional effects of CRP* expression in Escherichia coli.","date":"2009","source":"Journal of biological engineering","url":"https://pubmed.ncbi.nlm.nih.gov/19703305","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18021498","id":"PMC_18021498","title":"C-reactive protein (CRP): more than just an innocent bystander?","date":"2008","source":"Current medical research and opinion","url":"https://pubmed.ncbi.nlm.nih.gov/18021498","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24124618","id":"PMC_24124618","title":"Improving acetate tolerance of Escherichia coli by rewiring its global regulator cAMP receptor protein (CRP).","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24124618","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31594926","id":"PMC_31594926","title":"HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31594926","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27382112","id":"PMC_27382112","title":"Why cellular communication during plant reproduction is particularly mediated by CRP signalling.","date":"2016","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/27382112","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19193643","id":"PMC_19193643","title":"Profound asymmetry in the structure of the cAMP-free cAMP Receptor Protein (CRP) from Mycobacterium tuberculosis.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19193643","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23469036","id":"PMC_23469036","title":"Improving ethanol tolerance of Escherichia coli by rewiring its global regulator cAMP receptor protein (CRP).","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23469036","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19836632","id":"PMC_19836632","title":"Is there a relationship between high C-reactive protein (CRP) levels and dementia?","date":"2009","source":"Archives of gerontology and geriatrics","url":"https://pubmed.ncbi.nlm.nih.gov/19836632","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29967567","id":"PMC_29967567","title":"CRP Stimulates GDF15 Expression in Endothelial Cells through p53.","date":"2018","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/29967567","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24203355","id":"PMC_24203355","title":"Enhancing E. coli isobutanol tolerance through engineering its global transcription factor cAMP receptor protein (CRP).","date":"2013","source":"Biotechnology and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/24203355","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19502395","id":"PMC_19502395","title":"Sxy induces a CRP-S regulon in Escherichia coli.","date":"2009","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/19502395","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18022770","id":"PMC_18022770","title":"Genome scale portrait of cAMP-receptor protein (CRP) regulons in mycobacteria points to their role in pathogenesis.","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/18022770","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22566859","id":"PMC_22566859","title":"CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation.","date":"2011","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22566859","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1790210","id":"PMC_1790210","title":"Serum C-reactive protein (CRP) in horses: the effect of aging, sex, delivery and inflammations on its concentration.","date":"1991","source":"The Journal of veterinary medical science","url":"https://pubmed.ncbi.nlm.nih.gov/1790210","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17296319","id":"PMC_17296319","title":"C-reactive protein (CRP) as a marker in peripheral vascular disease.","date":"2007","source":"European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/17296319","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11741757","id":"PMC_11741757","title":"C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels.","date":"2001","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/11741757","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24452100","id":"PMC_24452100","title":"Rewiring global regulator cAMP receptor protein (CRP) to improve E. coli tolerance towards low pH.","date":"2014","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/24452100","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20710134","id":"PMC_20710134","title":"Usefulness of CRP and ESR in predicting septic joints.","date":"2010","source":"Southern medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20710134","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17113035","id":"PMC_17113035","title":"Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17113035","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28346363","id":"PMC_28346363","title":"Rapid and Low-Cost CRP Measurement by Integrating a Paper-Based Microfluidic Immunoassay with Smartphone (CRP-Chip).","date":"2017","source":"Sensors (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28346363","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22492993","id":"PMC_22492993","title":"C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22492993","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35028602","id":"PMC_35028602","title":"The association of anxiety and stress-related disorders with C-reactive protein (CRP) within UK Biobank.","date":"2021","source":"Brain, behavior, & immunity - health","url":"https://pubmed.ncbi.nlm.nih.gov/35028602","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12366834","id":"PMC_12366834","title":"MetR and CRP bind to the Vibrio harveyi lux promoters and regulate luminescence.","date":"2002","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12366834","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8142291","id":"PMC_8142291","title":"Androgen-dependent expression of cystatin-related protein (CRP) in the exorbital lacrimal gland of the rat.","date":"1994","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8142291","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2745572","id":"PMC_2745572","title":"Characteristics of the binding of human C-reactive protein (CRP) to laminin.","date":"1989","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2745572","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18761017","id":"PMC_18761017","title":"CRP binding and transcription activation at CRP-S sites.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18761017","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9157253","id":"PMC_9157253","title":"Transcriptional activation by FNR and CRP: reciprocity of binding-site recognition.","date":"1997","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9157253","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9337397","id":"PMC_9337397","title":"Human and murine PTX1/Ptx1 gene maps to the region for Treacher Collins syndrome.","date":"1997","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9337397","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19437230","id":"PMC_19437230","title":"CA-125 and CRP are elevated in preeclampsia.","date":"2009","source":"Hypertension in pregnancy","url":"https://pubmed.ncbi.nlm.nih.gov/19437230","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29105190","id":"PMC_29105190","title":"An acetylatable lysine controls CRP function in E. coli.","date":"2017","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29105190","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18374593","id":"PMC_18374593","title":"Comparison of procalcitonin and CrP in the postoperative course after lung decortication.","date":"2008","source":"European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/18374593","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18829218","id":"PMC_18829218","title":"C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism.","date":"2008","source":"Journal of vascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/18829218","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19146659","id":"PMC_19146659","title":"Computational prediction of cAMP receptor protein (CRP) binding sites in cyanobacterial genomes.","date":"2009","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19146659","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21725632","id":"PMC_21725632","title":"C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP.","date":"2011","source":"Analytical and bioanalytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21725632","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9186008","id":"PMC_9186008","title":"Flagellar photoresponses of ptx1, a nonphototactic mutant of Chlamydomonas.","date":"1997","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/9186008","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27127347","id":"PMC_27127347","title":"Associations of Trauma Severity with Mean Platelet Volume and Levels of Systemic Inflammatory Markers (IL1β, IL6, TNFα, and CRP).","date":"2016","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27127347","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16417509","id":"PMC_16417509","title":"A multitude of CRP/FNR-like transcription proteins in Bradyrhizobium japonicum.","date":"2006","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16417509","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8340178","id":"PMC_8340178","title":"The C-reactive protein (CRP) in patients with long bone fractures and after arthroplasty.","date":"1993","source":"International orthopaedics","url":"https://pubmed.ncbi.nlm.nih.gov/8340178","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21494362","id":"PMC_21494362","title":"Comparison of Serum CRP and Procalcitonin in Patients after Spine Surgery.","date":"2011","source":"Journal of Korean Neurosurgical Society","url":"https://pubmed.ncbi.nlm.nih.gov/21494362","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34933824","id":"PMC_34933824","title":"C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response.","date":"2021","source":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society","url":"https://pubmed.ncbi.nlm.nih.gov/34933824","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37741522","id":"PMC_37741522","title":"C-Reactive Protein (CRP) is Associated With Chronic Pain Independently of Biopsychosocial Factors.","date":"2023","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/37741522","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25687103","id":"PMC_25687103","title":"Engineering of global regulator cAMP receptor protein (CRP) in Escherichia coli for improved lycopene production.","date":"2015","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/25687103","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8260597","id":"PMC_8260597","title":"The mouse C-reactive protein (CRP) gene is expressed in response to IL-1 but not IL-6.","date":"1993","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/8260597","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33488610","id":"PMC_33488610","title":"Pronounced Diurnal Pattern of Salivary C-Reactive Protein (CRP) With Modest Associations to Circulating CRP Levels.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33488610","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3708910","id":"PMC_3708910","title":"CRP and neutrophils: functional effects and complex uptake.","date":"1986","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3708910","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31234146","id":"PMC_31234146","title":"C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms.","date":"2019","source":"Endocrine connections","url":"https://pubmed.ncbi.nlm.nih.gov/31234146","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21176092","id":"PMC_21176092","title":"A nutrient-sensitive interaction between Sirt1 and HNF-1α regulates Crp expression.","date":"2011","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/21176092","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27182730","id":"PMC_27182730","title":"Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27182730","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21539513","id":"PMC_21539513","title":"Pentraxins: CRP and PTX3 and cardiovascular disease.","date":"2011","source":"Inflammation & allergy drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/21539513","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31654094","id":"PMC_31654094","title":"Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes.","date":"2019","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/31654094","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28874380","id":"PMC_28874380","title":"The Global Regulatory Cyclic AMP Receptor Protein (CRP) Controls Multifactorial Fluoroquinolone Susceptibility in Salmonella enterica Serovar Typhimurium.","date":"2017","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/28874380","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16553865","id":"PMC_16553865","title":"Effect of the crp mutation on the utilization of transferrin-bound iron by Vibrio vulnificus.","date":"2006","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/16553865","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23274268","id":"PMC_23274268","title":"C-reactive protein (CRP) in different types of minimally invasive knee arthroplasty.","date":"2012","source":"Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA","url":"https://pubmed.ncbi.nlm.nih.gov/23274268","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37498420","id":"PMC_37498420","title":"Biosensors; noninvasive method in detection of C-reactive protein (CRP).","date":"2023","source":"Biomedical microdevices","url":"https://pubmed.ncbi.nlm.nih.gov/37498420","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34620864","id":"PMC_34620864","title":"Temporal evolution of master regulator Crp identifies pyrimidines as catabolite modulator factors.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34620864","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17338964","id":"PMC_17338964","title":"Dynamics of serum C-reactive protein (CRP) level and cosmophysical activity.","date":"2007","source":"European journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17338964","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11003649","id":"PMC_11003649","title":"Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11003649","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16176663","id":"PMC_16176663","title":"The antimicrobial properties of C-reactive protein (CRP).","date":"2005","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/16176663","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21329621","id":"PMC_21329621","title":"Serum CRP in patients with gout and effects of benzbromarone.","date":"2011","source":"International journal of clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21329621","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6600182","id":"PMC_6600182","title":"C-reactive protein- (CRP) mediated modulation of human B cell colony development.","date":"1983","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/6600182","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28588174","id":"PMC_28588174","title":"C-reactive Protein (CRP) as a Single Biomarker for Diagnosis of Neonatal Sepsis: A Comprehensive Meta-analysis.","date":"2017","source":"Mymensingh medical journal : MMJ","url":"https://pubmed.ncbi.nlm.nih.gov/28588174","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29771928","id":"PMC_29771928","title":"ChIP-exo interrogation of Crp, DNA, and RNAP holoenzyme interactions.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29771928","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27910861","id":"PMC_27910861","title":"Paper-based CRP Monitoring Devices.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27910861","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1455149","id":"PMC_1455149","title":"Rapid C-reactive protein (CRP) measurements in the diagnosis of acute appendicitis.","date":"1992","source":"Scandinavian journal of clinical and laboratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/1455149","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19188531","id":"PMC_19188531","title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.","date":"2009","source":"Psychosomatic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19188531","citation_count":2179,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32166607","id":"PMC_32166607","title":"A Review of Coronavirus Disease-2019 (COVID-19).","date":"2020","source":"Indian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32166607","citation_count":1485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18385676","id":"PMC_18385676","title":"Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18385676","citation_count":994,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26033244","id":"PMC_26033244","title":"Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α.","date":"2015","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26033244","citation_count":836,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18971492","id":"PMC_18971492","title":"Genetically elevated C-reactive protein and ischemic vascular disease.","date":"2008","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18971492","citation_count":665,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18997194","id":"PMC_18997194","title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.","date":"2008","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/18997194","citation_count":632,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19060910","id":"PMC_19060910","title":"Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19060910","citation_count":569,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19248087","id":"PMC_19248087","title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19248087","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21325005","id":"PMC_21325005","title":"Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.","date":"2011","source":"BMJ (Clinical research ed.)","url":"https://pubmed.ncbi.nlm.nih.gov/21325005","citation_count":524,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19567438","id":"PMC_19567438","title":"Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.","date":"2009","source":"JAMA","url":"https://pubmed.ncbi.nlm.nih.gov/19567438","citation_count":502,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19864399","id":"PMC_19864399","title":"A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein.","date":"2009","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/19864399","citation_count":498,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21979047","id":"PMC_21979047","title":"Complement factor H binds malondialdehyde epitopes and protects from oxidative stress.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21979047","citation_count":445,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21300955","id":"PMC_21300955","title":"Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels.","date":"2011","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/21300955","citation_count":426,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18464913","id":"PMC_18464913","title":"A genome-wide association study identifies protein quantitative trait loci (pQTLs).","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18464913","citation_count":390,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"265538","id":"PMC_265538","title":"Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).","date":"1977","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/265538","citation_count":390,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19240794","id":"PMC_19240794","title":"Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19240794","citation_count":355,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25190127","id":"PMC_25190127","title":"The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.","date":"2014","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25190127","citation_count":355,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19501581","id":"PMC_19501581","title":"Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.","date":"2009","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19501581","citation_count":334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32281668","id":"PMC_32281668","title":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.","date":"2020","source":"Journal of medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/32281668","citation_count":330,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18566104","id":"PMC_18566104","title":"C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.","date":"2008","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/18566104","citation_count":329,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17114654","id":"PMC_17114654","title":"C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.","date":"2006","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17114654","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2477488","id":"PMC_2477488","title":"Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages.","date":"1989","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2477488","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8599761","id":"PMC_8599761","title":"Three dimensional structure of human C-reactive protein.","date":"1996","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/8599761","citation_count":288,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18439548","id":"PMC_18439548","title":"Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.","date":"2008","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18439548","citation_count":275,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21592994","id":"PMC_21592994","title":"Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.","date":"2011","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21592994","citation_count":271,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22357713","id":"PMC_22357713","title":"Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study.","date":"2012","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22357713","citation_count":252,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47243,"output_tokens":3651,"usd":0.098247},"stage2":{"model":"claude-opus-4-6","input_tokens":6990,"output_tokens":2888,"usd":0.160725},"total_usd":0.563423,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":63242,"output_tokens":5187,"usd":0.133766},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7963,"output_tokens":2959,"usd":0.170685}},"stage1_raw":"Looking at the 100 papers, I need to identify those describing mechanistic findings about the human CRP gene (C-reactive protein). Many papers are about bacterial CRP (cAMP receptor protein in E. coli and other bacteria), plant CRPs, or Ptx1/Pitx1 (a completely different gene that shares no function with human CRP). I need to focus only on human/mammalian C-reactive protein mechanistic findings.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"Human CRP binds to the basement membrane protein laminin in vitro in a Ca2+-dependent manner via its phosphorylcholine (PC) binding site; binding was saturable (molar ratio ~4 CRP/laminin), inhibited by soluble PC and anti-idiotypic mAbs directed to the PC-binding site, and required a Ca2+-induced conformational change in the CRP molecule.\",\n      \"method\": \"In vitro binding assay with labeled CRP, inhibition by unlabeled CRP, soluble PC, and anti-idiotypic mAbs; Ca2+/EDTA manipulation\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal inhibition approaches in vitro, single lab\",\n      \"pmids\": [\"2745572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Mouse CRP gene expression in hepatocytes is induced by IL-1 but not IL-6, in contrast to human CRP which is strongly induced by IL-6; the IL-1 effect appears to operate at the post-transcriptional level rather than transcriptionally, as C/EBP elements in a pCAT construct failed to respond to IL-1 in hepatoma cells.\",\n      \"method\": \"Primary hepatocyte culture with cytokine stimulation; CAT reporter transfection assay in Hep 3B2 cells\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with reporter construct and primary cells, single lab\",\n      \"pmids\": [\"8260597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Autoantibodies to CRP in SLE and related autoimmune diseases target non-native epitopes on the CRP molecule (modified CRP), as demonstrated by adsorption studies showing that the main antigenic targets are cryptic epitopes exposed on modified CRP rather than native pentameric CRP.\",\n      \"method\": \"ELISA for anti-CRP IgG; adsorption studies with native vs. modified CRP\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, serological assay with adsorption controls\",\n      \"pmids\": [\"9737658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Solid-phase CRP binding to phosphorylcholine (PC) triggers classical complement pathway activation (C1q, C4, C3c deposition) in a dose-dependent manner; at high CRP concentrations (>150 mg/L), fluid-phase CRP-C1q interaction competes with and down-regulates solid-phase complement activation.\",\n      \"method\": \"Ellipsometry measuring protein deposition on PC-coated surfaces; radial immunodiffusion for fluid-phase CRP-C1q interaction; antibody detection of complement components\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reconstitution on defined surfaces with multiple complement component readouts and mechanistic follow-up, single lab\",\n      \"pmids\": [\"17113035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CRP induces secretion of chemokines CCL2, CCL3, and CCL4 from adherent human monocytes through binding to Fcγ receptors CD32a, CD32b, and CD64; this is coupled to CRP-induced upregulation of Mac-1 (CD11b) and ICAM-1, and blockade of Mac-1/ICAM-1 interaction inhibits CRP-induced chemokine secretion. CRP also reduces surface expression of chemokine receptors CCR1, CCR2, and CCR5 secondary to chemokine secretion, and reduces monocyte migration toward CCL2 and CCL3.\",\n      \"method\": \"ELISA for chemokine secretion; flow cytometry for receptor expression; Boyden chamber migration assay; neutralizing antibody blockade; adherent vs. suspension culture comparison\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ELISA, flow cytometry, migration assay, antibody blockade), receptor identification, mechanism defined, single lab\",\n      \"pmids\": [\"18591415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CRP and anti-CRP autoantibodies assemble on the surface of secondary necrotic cells (SNEC) to form a ternary complex that switches phagocytic clearance toward a pro-inflammatory cytokine response when cleared by macrophages in vitro.\",\n      \"method\": \"In vitro binding assay to SNEC; macrophage phagocytosis assay; cytokine measurement by ELISA\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional phagocytosis assay with defined pro-inflammatory readout, single lab\",\n      \"pmids\": [\"22566859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"An RNA aptamer binds specifically to monomeric CRP (mCRP) but not to pentameric CRP (pCRP); biological activity of the mCRP isoform was confirmed by its binding to complement protein C1q, distinguishing the two CRP isoforms functionally.\",\n      \"method\": \"Fluorescence anisotropy binding assay; polyacrylamide gel and total internal reflection fluorescence microscopy; C1q binding confirmation\",\n      \"journal\": \"Analytical and bioanalytical chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple detection methods confirming isoform-specific binding and C1q functional validation, single lab\",\n      \"pmids\": [\"21725632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sirt1 physically interacts with HNF-1α in vitro and, under nutrient-restricting conditions in vivo, co-localizes on HNF-1α binding sites in the Crp promoter; this interaction suppresses HNF-1α transcriptional activity and Crp expression in mouse primary hepatocytes, accompanied by decreased acetylation of histone H4 lysine 16 at these promoter sites.\",\n      \"method\": \"Co-IP (in vitro and in vivo); ChIP assay on Crp promoter; pharmacological Sirt1 inhibition; primary hepatocyte culture with nutrient restriction; fasted mouse liver analysis\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (co-IP, ChIP, pharmacological inhibition, in vivo nutrient restriction), single lab with rigorous controls\",\n      \"pmids\": [\"21176092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CRP stimulates GDF15 transcription in human aortic endothelial cells through p53; CRP treatment or CRP plasmid transfection induced GDF15 promoter luciferase activity, and ChIP assays confirmed p53 recruitment to both p53 binding sites in the GDF15 promoter in response to CRP.\",\n      \"method\": \"Dual-luciferase reporter assay; ChIP assay; CRP plasmid transfection; in vitro CRP treatment of HAECs\",\n      \"journal\": \"Mediators of inflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay plus ChIP confirmation of transcription factor recruitment, single lab\",\n      \"pmids\": [\"29967567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRP stimulation of pancreatic neuroendocrine tumor cell lines (BON1, QGP1) increases IL-6 secretion and invasion, accompanied by activation/phosphorylation of ERK, AKT, and/or STAT3 signaling pathways; CRP was taken up by pNEN cells despite absence of classical CRP receptors CD16, CD32, and CD64 on these cells.\",\n      \"method\": \"ELISA for IL-6; Western blot for pathway phosphorylation; invasion assay; flow cytometry for receptor expression; immunocytochemistry for CRP uptake\",\n      \"journal\": \"Endocrine connections\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in cell lines with pathway identification, single lab\",\n      \"pmids\": [\"31234146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Leflunomide induces AHR-ARNT interaction to inhibit hepatic CRP production; in high-CRP conditions, upregulated HIF1α competes with AHR for ARNT association and blocks this Leflunomide-AHR-CRP signaling; hepatocyte-specific HIF1α deletion or pharmacological HIF1α inhibition (Acriflavine) re-activates the AHR-ARNT pathway and restores CRP suppression.\",\n      \"method\": \"Hepatocyte-specific HIF1α knockout mouse model; pharmacological inhibition; co-IP for AHR-ARNT interaction; in vivo arthritic rat model; serum CRP measurements\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic (conditional KO) and pharmacological approaches with defined molecular mechanism (AHR-ARNT-HIF1α competition), replicated across multiple models\",\n      \"pmids\": [\"31594926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Ruxolitinib (JAK1/2 inhibitor) fully inhibits LPS-induced CRP secretion and mRNA expression in primary human hepatocytes and HepaRG cells (IC50 = 12.9 nM), acting through blockade of the IL-6/JAK/STAT signaling cascade; neutralizing the IL-6 receptor with tocilizumab also prevented CRP induction, placing CRP downstream of the IL-6/JAK/STAT pathway.\",\n      \"method\": \"Primary human hepatocyte culture; HepaRG cells; qRT-PCR for CRP mRNA; ELISA for CRP secretion; pharmacological JAK inhibition and IL-6R neutralization; multiple TLR agonist and cytokine stimulations\",\n      \"journal\": \"Inflammation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with multiple stimuli, pathway confirmed by receptor neutralization, single lab with rigorous controls\",\n      \"pmids\": [\"31654094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"Human CRP modulates B cell colony formation: at 10-25 µg/mL CRP augments SpA-induced B cell colony numbers, with optimal effect during early colony formation; at higher concentrations CRP causes focal disintegration of colony clusters; a small frequency of CRP-binding cells was detected by flow cytometry after CRP pre-incubation.\",\n      \"method\": \"Semisolid B cell colony assay; flow microcytofluorometry for CRP-binding cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional assay with dose-response, single lab, no receptor identification\",\n      \"pmids\": [\"6600182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"CRP-mediated uptake of pneumococcal C-polysaccharide (CPS) by neutrophils occurs through a specific CRP-dependent mechanism that promotes CPS clearance, further enhanced by complement activation; physiological concentrations of LDL inhibit entry of CRP-complexed CPS into neutrophils but have no effect on CRP alone; CRP has no effect on neutrophil chemotaxis or oxidative metabolism.\",\n      \"method\": \"Neutrophil uptake assay with CRP-CPS complexes; LDL inhibition experiment; chemotaxis and oxidative metabolism assays\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional uptake assay with defined inhibition conditions and multiple cellular readouts, single lab\",\n      \"pmids\": [\"3708910\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human C-reactive protein (CRP) is a Ca2+-dependent, phosphorylcholine-binding pentraxin produced primarily by hepatocytes downstream of the IL-6/JAK/STAT signaling cascade (suppressed by the Sirt1–HNF-1α axis under nutrient restriction and by AHR-ARNT signaling); it exists as pentameric (pCRP) and monomeric (mCRP) isoforms with distinct activities, binds Fcγ receptors (CD32a/b, CD64) on monocytes to induce chemokine secretion and Mac-1/ICAM-1-dependent retention, activates the classical complement pathway through C1q (with fluid-phase CRP–C1q interaction self-limiting activation at high concentrations), opsonizes apoptotic/necrotic cell debris for phagocytic clearance, binds laminin via its PC-binding site to concentrate at sites of tissue damage, and can activate intracellular ERK/AKT/STAT3 signaling and p53-dependent GDF15 transcription in target cells.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI need to carefully classify each paper before extracting discoveries.\n\n**Classification process:**\n\nThe target gene is human CRP (C-reactive protein, the acute-phase protein).\n\nPapers to EXCLUDE:\n- [2], [4], [9], [18], [22], [33], [64] — about Ptx1/PITX1 (pituitary homeobox 1), alias collision\n- [11], [14], [30], [31], [36], [37], [39], [42], [43], [46], [47], [48], [53], [59], [62], [63], [66], [69], [73], [78], [87], [88], [91], [98] — about bacterial/microbial CRP (cAMP receptor protein / catabolite repression protein), symbol collision\n- [27] (corpus) — Transcriptomic profiling of Yersinia CRP regulon — bacterial CRP, EXCLUDE\n- [41] — plant CRP (cysteine-rich peptides), symbol collision, EXCLUDE\n- [60] — cystatin-related protein (CRP) in rat lacrimal gland — different protein, alias collision, EXCLUDE\n- [71] — ptx1 mutant in Chlamydomonas — EXCLUDE\n- [93] — Ptx1 repression of IFN-A — EXCLUDE\n- [94] — horseshoe crab CRP2 — non-orthologous organism with fundamentally different protein context, EXCLUDE\n\nAdditional curated papers:\n- [3] BioPlex interactome — no specific CRP mechanism\n- [4] lung cancer GWAS — no CRP mechanism\n- [5] proteome interactome — no specific CRP mechanism\n- [9] Gene Ontology — no CRP mechanism\n- Most curated papers are epidemiological/GWAS — exclude from mechanistic extraction\n\n**KEEP papers with mechanistic content:**\n- [19] (corpus): Osmand 1977 — pentraxin structure, cyclic pentameric symmetry — KEEP\n- [27] (corpus, PMID:265538 in curated): same paper — KEEP\n- [61] (corpus): CRP binds laminin via phosphocholine binding site, Ca2+-dependent — KEEP\n- [34] (corpus): Pentraxins, Fcγ receptors as primary receptors for CRP — KEEP\n- [55] (corpus): CRP-C1q interaction, complement activation — KEEP\n- [35] (corpus): CRP induces chemokine secretion via CD11b/ICAM-1 on monocytes — KEEP\n- [29] (corpus): CRP directly binds leptin — KEEP\n- [49] (corpus): CRP/anti-CRP on secondary necrotic cells, pro-inflammatory — KEEP\n- [70] (corpus): RNA aptamer binds monomeric CRP not pentameric — KEEP\n- [45] (corpus): CRP induces GDF15 via p53 in endothelial cells — KEEP\n- [82] (corpus): CRP promotes malignancy in pNEN via ERK/AKT/STAT3 — KEEP\n- [83] (corpus): Sirt1/HNF-1α regulates Crp expression — KEEP\n- [79] (corpus): Mouse CRP induced by IL-1 not IL-6 — KEEP\n- [86] (corpus): Ruxolitinib inhibits CRP via IL6/JAK/STAT — KEEP\n- [81] (corpus): CRP-CPS complex uptake by neutrophils — KEEP\n- [96] (corpus): CRP modulates B cell colony development — KEEP\n- [8] (corpus): IL-1, IL-6, IL-17 induce CRP in liver — KEEP\n- [40] (corpus): HIF1α/AHR/ARNT/CRP signaling — KEEP\n- [26] (curated): Shrive 1996 — 3D crystal structure of CRP — KEEP\n- [27] (curated, PMID:265538): Osmand 1977 pentraxin — KEEP\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1977,\n      \"finding\": \"Human C-reactive protein and the complement subcomponent C1t are structurally homologous proteins (pentraxins) composed of five subunits arranged in cyclic pentameric symmetry, as revealed by partial amino acid sequencing and negative-stain electron microscopy.\",\n      \"method\": \"Amino acid sequencing and negative-stain electron microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct structural characterization by sequencing and EM, foundational discovery replicated extensively\",\n      \"pmids\": [\"265538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Human CRP binds to the basement membrane protein laminin in vitro in a Ca2+-dependent manner via its phosphocholine (PC) binding site, providing a mechanism for selective CRP deposition at inflamed sites. The binding requires Ca2+-induced conformational change in CRP and was inhibitable by soluble PC and anti-PC-site monoclonal antibodies.\",\n      \"method\": \"In vitro binding assay with radiolabeled CRP, inhibition by soluble PC and anti-idiotypic mAbs directed to PC-binding site\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with ligand competition and site-specific antibody inhibition\",\n      \"pmids\": [\"2745572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Mouse CRP (moCRP) gene expression is tissue-specific to liver and induced by IL-1 but not IL-6 in isolated hepatocytes, contrasting with human CRP where IL-6 is the dominant inducer. IL-1 may act post-transcriptionally rather than transcriptionally on the moCRP gene.\",\n      \"method\": \"Isolated mouse hepatocyte culture, cytokine stimulation, gene expression analysis, CAT reporter transfection\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cell-based assay with cytokine dissection and reporter assay, single study\",\n      \"pmids\": [\"8260597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The three-dimensional crystal structure of human CRP reveals that phosphocholine binding is mediated through calcium ions and a hydrophobic pocket centered on Phe66, with Glu81 positioned to interact with the choline group. A cleft on the pentameric face opposite the calcium site may have an important functional role.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional site identification\",\n      \"pmids\": [\"8599761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"CRP-pneumococcal C-polysaccharide (CPS) complexes are taken up by neutrophils via a specific CRP-dependent mechanism that promotes CPS clearance, further enhanced by complement activation. Physiological concentrations of low-density lipoprotein inhibit entry of complexed CPS but not CRP alone into neutrophils. Pure CRP has no effect on neutrophil chemotaxis or oxidative metabolism.\",\n      \"method\": \"Neutrophil uptake assays, complement activation, LDL inhibition experiments\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay with defined ligand/receptor interactions, single study\",\n      \"pmids\": [\"3708910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"Human CRP modulates human B cell colony formation stimulated by Staphylococcal protein A: CRP at 10–25 µg/mL augments colony numbers at early stages, while higher concentrations cause focal disintegration of colony clusters at later stages. CRP-binding cells were detectable by flow cytometry after pre-incubation.\",\n      \"method\": \"Semisolid B cell colony assay, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional cell-based assay with clear dose-response and kinetic analysis, single study\",\n      \"pmids\": [\"6600182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CRP-induced classical complement activation on solid-phase phosphocholine-containing surfaces is efficiently down-regulated at CRP concentrations >150 mg/L, through fluid-phase CRP-C1q interaction that competitively inhibits solid-phase complement activation. This constitutes a self-limiting mechanism of complement regulation.\",\n      \"method\": \"Ellipsometry measuring protein deposition on PC-KLH surfaces, radial immunodiffusion for CRP-C1q fluid-phase interaction\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biophysical measurement of complement activation with mechanistic inhibition demonstrated\",\n      \"pmids\": [\"17113035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CRP induces secretion of chemokines CCL2, CCL3, and CCL4 from human adherent monocytes through binding to Fcγ receptors CD32a, CD32b, and CD64. This is accompanied by CRP-induced upregulation of Mac-1 (CD11b) and ICAM-1 on adherent monocytes, and blockade of Mac-1/ICAM-1 interaction inhibits the CRP-induced chemokine secretion. CRP also reduces surface expression of chemokine receptors CCR1, CCR2, and CCR5 as a consequence of chemokine secretion.\",\n      \"method\": \"ELISA, flow cytometry, real-time RT-PCR, Boyden chamber migration assay, blocking antibodies\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with receptor blockade mechanistic dissection\",\n      \"pmids\": [\"18591415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Proinflammatory cytokines IL-1, IL-6, and IL-17 induce CRP production in the liver by signaling through their receptors on hepatic cells, activating kinases and phosphatases that lead to translocation of transcription factors to the CRP gene promoter.\",\n      \"method\": \"Review synthesizing molecular signaling studies in hepatic cells\",\n      \"journal\": \"Advances in clinical chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — review/synthesis paper, no direct new experimental data\",\n      \"pmids\": [\"19803417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Fcγ receptors (FcγRs) serve as the primary receptors for pentraxins CRP and SAP, mediating their opsonic functions and clearance of apoptotic cells. The crystal structure of SAP in complex with FcγRIIa was solved, revealing structural basis for pentraxin-receptor interaction relevant to CRP function.\",\n      \"method\": \"Crystal structure of SAP-FcγRIIa complex, functional studies of Fcγ receptor-mediated clearance\",\n      \"journal\": \"Current opinion in organ transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 for SAP/Tier 3 for CRP inference — crystal structure for SAP provides structural framework for CRP Fcγ receptor interaction\",\n      \"pmids\": [\"21150611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CRP bound to the surface of secondary necrotic cells (SNEC) serves as a target for anti-CRP autoantibodies. The ternary complex of CRP, anti-CRP autoantibodies, and SNEC is cleared by macrophages in vitro and induces a pro-inflammatory cytokine response, switching phagocytic clearance toward inflammation.\",\n      \"method\": \"In vitro macrophage phagocytosis assay, cytokine measurement by ELISA\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional in vitro assay with defined molecular components, single study\",\n      \"pmids\": [\"22566859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CRP directly binds leptin in extracellular settings, impairing leptin's biological actions and contributing to leptin resistance. In vitro, leptin promotes CRP production from hepatocytes and endothelial cells.\",\n      \"method\": \"In vitro binding assays, hepatocyte and endothelial cell culture experiments\",\n      \"journal\": \"Current pharmaceutical design\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — based on a review summarizing binding studies; limited mechanistic detail provided\",\n      \"pmids\": [\"23688010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sirt1 physically interacts with HNF-1α in vitro and in vivo under nutrient-restricting conditions to suppress HNF-1α transcriptional activity and the expression of its target gene Crp in mouse primary hepatocytes. Sirt1 and HNF-1α co-localize on two HNF-1α binding sites on the Crp promoter, leading to decreased acetylation of histone H4 lysine 16 at these sites specifically under nutrient restriction. Pharmacological inhibition of Sirt1 blocks nutrient restriction-mediated Crp suppression.\",\n      \"method\": \"Co-immunoprecipitation, ChIP assay, primary hepatocyte culture, pharmacological Sirt1 inhibition, histone acetylation analysis\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal interaction demonstrated in vitro and in vivo with ChIP, histone modification, and pharmacological validation; multiple orthogonal methods\",\n      \"pmids\": [\"21176092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"An RNA aptamer binds specifically to monomeric CRP (mCRP) but not to pentameric CRP (pCRP), enabling discrimination between the two isoforms. Monomeric CRP prepared from heated pCRP shows biological activity confirmed by binding to complement protein C1q.\",\n      \"method\": \"Fluorescence anisotropy aptamer binding assay, gel electrophoresis, TIRF microscopy, C1q binding confirmation\",\n      \"journal\": \"Analytical and bioanalytical chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay distinguishing isoforms with functional validation of mCRP activity\",\n      \"pmids\": [\"21725632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CRP induces GDF15 expression in human aortic endothelial cells (HAECs) through p53. CRP treatment or CRP plasmid transfection into HAECs increases GDF15 promoter activity (confirmed by dual-luciferase reporter assay), and ChIP assays confirm that p53 is recruited to both p53 binding sites in the GDF15 promoter in response to CRP.\",\n      \"method\": \"In vitro CRP treatment, CRP plasmid transfection, dual-luciferase reporter assay, ChIP assay\",\n      \"journal\": \"Mediators of inflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and reporter assay establish p53 recruitment to GDF15 promoter downstream of CRP, single study\",\n      \"pmids\": [\"29967567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In pancreatic neuroendocrine neoplasm cells (BON1), CRP stimulation increases IL-6 secretion and invasion, accompanied by activation/phosphorylation of ERK, AKT, and STAT3 pathways. IL-6 exposure upregulates CRP expression and secretion in these cells. CRP is taken up by pNEN cells despite absence of classical CRP receptors CD16, CD32, and CD64.\",\n      \"method\": \"ELISA, Western blot, flow cytometry, immunocytochemistry, invasion and proliferation assays\",\n      \"journal\": \"Endocrine connections\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays with pathway analysis in human cell lines, single study\",\n      \"pmids\": [\"31234146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Leflunomide inhibits hepatic CRP production through an AHR-ARNT interaction pathway. In CRPH (high CRP) arthritic rats, elevated CRP upregulates HIF1α, which competitively displaces AHR from ARNT association, thereby blocking Leflunomide-AHR-CRP signaling. Hepatocyte-specific HIF1α deletion or pharmacological HIF1α inhibition (acriflavine) restores AHR-ARNT interaction and CRP suppression.\",\n      \"method\": \"In vivo rat arthritis model, hepatocyte-specific gene deletion, co-immunoprecipitation of AHR-ARNT, pharmacological HIF1α inhibition, serum CRP measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological epistasis in vivo with Co-IP demonstrating competitive mechanism, multiple orthogonal approaches\",\n      \"pmids\": [\"31594926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Ruxolitinib (JAK1/2 inhibitor) potently represses CRP secretion and mRNA expression in inflammatory human hepatocytes (primary hepatocytes and HepaRG cells) induced by LPS, Toll-like receptor agonists, or pro-inflammatory cytokines (IL-1β, IL-6, TNFα). The mechanism involves blocking the IL-6/JAK/STAT signaling cascade; anti-IL-6 receptor antibody tocilizumab similarly prevents CRP induction, placing JAK/STAT downstream of IL-6 receptor in CRP regulation.\",\n      \"method\": \"Primary human hepatocyte and HepaRG cell culture, ruxolitinib and tocilizumab pharmacological inhibition, CRP mRNA and protein measurement\",\n      \"journal\": \"Inflammation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with orthogonal pathway inhibitors in human primary cells establishes IL6/JAK/STAT as the mechanistic pathway for CRP induction\",\n      \"pmids\": [\"31654094\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human CRP is a pentameric acute-phase protein (pentraxin) whose subunits bind phosphocholine-containing ligands via Ca2+-dependent interaction at a hydrophobic pocket centered on Phe66/Glu81; CRP is produced primarily in the liver under control of IL-6/JAK/STAT and IL-1 signaling (with HNF-1α and Sirt1 as nutrient-sensitive transcriptional regulators), circulates as a pentamer that activates complement via C1q and is opsonized through Fcγ receptors, undergoes conformational conversion to a monomeric form (mCRP) with distinct biological activities including C1q binding and pro-inflammatory signaling, and in vascular and immune cells activates ERK/AKT/STAT3 pathways, induces chemokine secretion via Mac-1/ICAM-1, and regulates downstream genes (e.g., GDF15) through p53 recruitment.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CRP is a Ca²⁺-dependent pentraxin acute-phase protein produced primarily by hepatocytes under the control of IL-6/JAK/STAT signaling, with transcriptional suppression mediated by the Sirt1–HNF-1α axis during nutrient restriction and by AHR-ARNT signaling competing with HIF-1α [PMID:31654094, PMID:21176092, PMID:31594926]. CRP exists as pentameric (pCRP) and monomeric (mCRP) isoforms with distinct ligand-binding properties; it binds phosphorylcholine and laminin via its PC-binding site in a Ca²⁺-dependent manner, activates the classical complement pathway through C1q (with fluid-phase CRP self-limiting activation at high concentrations), and opsonizes bacterial polysaccharides and necrotic cell debris for phagocytic clearance [PMID:2745572, PMID:17113035, PMID:21725632, PMID:3708910, PMID:22566859]. CRP engages Fcγ receptors (CD32a/b, CD64) on monocytes to induce chemokine secretion (CCL2, CCL3, CCL4) through Mac-1/ICAM-1–dependent signaling, while simultaneously downregulating cognate chemokine receptors to reduce monocyte migration, thereby promoting monocyte retention at inflammatory sites [PMID:18591415]. In target cells, CRP activates ERK, AKT, and STAT3 phosphorylation and stimulates p53-dependent GDF15 transcription [PMID:31234146, PMID:29967567].\",\n  \"teleology\": [\n    {\n      \"year\": 1983,\n      \"claim\": \"Early evidence established that CRP modulates immune cell behavior in a dose-dependent manner, raising the question of whether CRP acts as more than a passive opsonin by directly influencing lymphocyte proliferation.\",\n      \"evidence\": \"Semisolid B cell colony assay with dose-response CRP treatment and flow cytometric detection of CRP-binding cells\",\n      \"pmids\": [\"6600182\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No receptor identified for CRP on B cells\", \"Single lab, not independently replicated\", \"Mechanism of augmentation vs. disintegration at different concentrations unresolved\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"CRP was shown to function as an opsonin for bacterial polysaccharides, establishing that CRP promotes pathogen clearance through neutrophil uptake enhanced by complement, while LDL antagonizes this process.\",\n      \"evidence\": \"Neutrophil uptake assay with CRP-CPS complexes, LDL inhibition, and chemotaxis/oxidative metabolism controls\",\n      \"pmids\": [\"3708910\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The specific neutrophil receptor mediating CRP-dependent uptake was not identified\", \"Whether LDL inhibition is physiologically limiting in vivo was not tested\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Identification of laminin as a CRP ligand via the PC-binding site explained how CRP concentrates at sites of tissue damage by engaging exposed basement membrane components.\",\n      \"evidence\": \"In vitro binding assays with labeled CRP, competitive inhibition by PC and anti-idiotypic antibodies, and Ca²⁺/EDTA manipulation\",\n      \"pmids\": [\"2745572\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of CRP–laminin binding at inflammatory foci not demonstrated\", \"Whether laminin binding triggers downstream signaling was not tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Species-specific cytokine regulation of CRP was delineated: mouse CRP responds to IL-1 post-transcriptionally rather than to IL-6, contrasting with human CRP, establishing that transcriptional control of the CRP locus differs between species.\",\n      \"evidence\": \"Primary hepatocyte culture with cytokine stimulation and CAT reporter transfection in hepatoma cells\",\n      \"pmids\": [\"8260597\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Post-transcriptional mechanism of IL-1 induction not molecularly defined\", \"Direct comparison of human and mouse promoter elements not performed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The mechanism by which CRP activates complement was resolved: solid-phase CRP triggers classical pathway activation via C1q/C4/C3c deposition, while fluid-phase CRP–C1q interaction at high concentrations acts as a self-limiting brake on complement activation.\",\n      \"evidence\": \"Ellipsometry on PC-coated surfaces with complement component deposition measurements and radial immunodiffusion for fluid-phase CRP–C1q\",\n      \"pmids\": [\"17113035\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Self-limiting mechanism not validated in vivo with physiological complement concentrations\", \"Relative contributions of mCRP vs. pCRP to complement activation not distinguished\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The monocyte signaling mechanism downstream of CRP was established: CRP binds Fcγ receptors CD32a/b and CD64 to induce chemokine secretion (CCL2, CCL3, CCL4) via Mac-1/ICAM-1-dependent adhesion, while simultaneously downregulating chemokine receptors to reduce migration — thus retaining monocytes at inflammatory sites.\",\n      \"evidence\": \"ELISA, flow cytometry, Boyden chamber migration, and neutralizing antibody blockade in adherent human monocytes\",\n      \"pmids\": [\"18591415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling cascade downstream of Fcγ receptor engagement by CRP not mapped\", \"Whether this retention mechanism operates in tissue macrophages in vivo not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Two key advances refined CRP biology: (1) mCRP was functionally distinguished from pCRP by isoform-specific C1q binding, and (2) the Sirt1–HNF-1α axis was identified as a transcriptional suppressor of CRP via promoter deacetylation under nutrient restriction, linking metabolic sensing to acute-phase regulation.\",\n      \"evidence\": \"RNA aptamer isoform-specific binding assays with C1q validation (mCRP); co-IP, ChIP on CRP promoter, pharmacological Sirt1 inhibition, and fasted mouse liver analysis (Sirt1–HNF-1α)\",\n      \"pmids\": [\"21725632\", \"21176092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for mCRP-specific C1q engagement unresolved\", \"Whether Sirt1 regulation of CRP operates in human hepatocytes not shown\", \"Relative contributions of pCRP vs. mCRP to complement activation in vivo unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"CRP was shown to opsonize secondary necrotic cells (SNEC), but anti-CRP autoantibodies redirect this clearance toward pro-inflammatory cytokine production by macrophages, explaining how autoimmunity to CRP may amplify inflammation in diseases like SLE.\",\n      \"evidence\": \"In vitro SNEC binding, macrophage phagocytosis assay, and ELISA for cytokine measurement\",\n      \"pmids\": [\"22566859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo pathogenic role of CRP-anti-CRP complexes on SNEC not demonstrated\", \"Whether mCRP or pCRP preferentially opsonizes SNEC not determined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"CRP was found to act as an upstream signal for GDF15 transcription in endothelial cells through p53 recruitment to the GDF15 promoter, revealing a direct transcription-regulatory output of CRP signaling in vascular cells.\",\n      \"evidence\": \"Dual-luciferase reporter assay and ChIP for p53 at GDF15 promoter in human aortic endothelial cells\",\n      \"pmids\": [\"29967567\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating CRP signal to p53 in endothelial cells not identified\", \"Physiological relevance of CRP-induced GDF15 in vivo not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Three studies converged to define both upstream and downstream signaling of CRP: (1) CRP production is driven by IL-6/JAK/STAT and suppressible by ruxolitinib; (2) AHR-ARNT signaling suppresses CRP, but HIF-1α competes for ARNT to de-repress CRP under high-inflammation conditions; (3) CRP activates ERK/AKT/STAT3 in target cells even without classical Fcγ receptors, via internalization.\",\n      \"evidence\": \"JAK inhibitor and IL-6R neutralization in primary hepatocytes (IL-6/JAK/STAT); hepatocyte-specific HIF-1α KO mice and AHR-ARNT co-IP (AHR pathway); Western blot for pathway phosphorylation and invasion assay in pNEN cell lines (ERK/AKT/STAT3)\",\n      \"pmids\": [\"31654094\", \"31594926\", \"31234146\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Non-Fcγ receptor mechanism of CRP internalization in tumor cells uncharacterized\", \"How AHR-ARNT and Sirt1-HNF-1α suppressive pathways are coordinated at the CRP promoter is unknown\", \"Whether CRP-induced ERK/AKT/STAT3 signaling is relevant in non-tumor cell types not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The receptor(s) mediating CRP internalization and signaling in cells lacking classical Fcγ receptors remain unidentified, and the structural basis for differential activities of pCRP vs. mCRP isoforms in vivo is unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No non-Fcγ CRP receptor has been molecularly identified\", \"No crystal structure of mCRP–C1q complex available\", \"In vivo relative abundance and interconversion kinetics of pCRP and mCRP at inflammatory sites undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 9, 12]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [3, 4, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 4, 5, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"C1q\", \"HNF1A\", \"SIRT1\", \"ARNT\", \"ICAM1\", \"ITGAM\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"CRP is a liver-derived pentameric acute-phase pentraxin that recognizes phosphocholine-containing ligands through a Ca²⁺-dependent hydrophobic pocket centered on Phe66 and Glu81, enabling opsonization of pathogens and damaged cells and activation of the classical complement pathway via C1q [PMID:265538, PMID:8599761, PMID:17113035]. Hepatic CRP transcription is driven principally by IL-6/JAK/STAT signaling, with contributions from IL-1 and IL-17, and is negatively regulated by Sirt1-mediated deacetylation of histone H4K16 at HNF-1α-occupied promoter sites under nutrient restriction [PMID:31654094, PMID:21176092]. CRP engages Fcγ receptors on monocytes and neutrophils to promote phagocytic clearance and chemokine secretion (CCL2, CCL3, CCL4) through Mac-1/ICAM-1-dependent signaling, and in vascular and neoplastic cells activates ERK, AKT, and STAT3 pathways that induce IL-6 secretion and p53-dependent GDF15 expression [PMID:18591415, PMID:31234146, PMID:29967567]. Pentameric CRP can undergo conformational dissociation to a monomeric form (mCRP) that retains C1q binding but exhibits distinct biological activities [PMID:21725632].\",\n  \"teleology\": [\n    {\n      \"year\": 1977,\n      \"claim\": \"Establishing the pentameric architecture of CRP resolved its quaternary structure and placed it in the pentraxin superfamily alongside complement C1t, providing the structural framework for all subsequent functional studies.\",\n      \"evidence\": \"Amino acid sequencing and negative-stain electron microscopy of purified human CRP\",\n      \"pmids\": [\"265538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic-resolution structure not yet available\",\n        \"Ligand-binding site unidentified at this resolution\"\n      ]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Demonstrating that CRP–C-polysaccharide complexes are taken up by neutrophils in a complement-enhanced manner established CRP as a functional opsonin, linking ligand recognition to phagocytic clearance.\",\n      \"evidence\": \"Neutrophil uptake assays with CRP–CPS complexes, complement activation, and LDL inhibition experiments\",\n      \"pmids\": [\"3708910\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific neutrophil receptor for CRP not identified\",\n        \"In vivo relevance of LDL inhibition of CRP uptake not tested\"\n      ]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Showing that CRP binds laminin through its phosphocholine-binding site in a Ca²⁺-dependent manner extended CRP's ligand repertoire beyond microbial polysaccharides to extracellular matrix components at inflamed sites.\",\n      \"evidence\": \"Radiolabeled CRP binding assays with laminin, inhibited by soluble phosphocholine and anti-PC-site monoclonal antibodies\",\n      \"pmids\": [\"2745572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of laminin recognition not resolved\",\n        \"Functional consequence of CRP–laminin interaction in tissue inflammation not demonstrated in vivo\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"The crystal structure of human CRP revealed the atomic basis of phosphocholine recognition — Ca²⁺ ions and a hydrophobic pocket centered on Phe66 with Glu81 contacting choline — answering how CRP discriminates its primary ligand.\",\n      \"evidence\": \"X-ray crystallography of human CRP\",\n      \"pmids\": [\"8599761\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional role of the cleft on the opposite pentameric face undefined\",\n        \"No co-crystal with C1q or Fcγ receptor available\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that fluid-phase CRP at high concentrations competitively inhibits solid-phase C1q-mediated complement activation revealed a self-limiting mechanism preventing excessive complement damage during severe inflammation.\",\n      \"evidence\": \"Ellipsometry on PC-KLH surfaces measuring complement protein deposition at varying CRP concentrations\",\n      \"pmids\": [\"17113035\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo validation of the self-limiting threshold not performed\",\n        \"Structural basis for differential C1q engagement by soluble versus surface-bound CRP unknown\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of Fcγ receptors CD32a, CD32b, and CD64 as CRP receptors on monocytes, with downstream Mac-1/ICAM-1-dependent chemokine secretion, defined the molecular pathway by which CRP orchestrates innate immune cell recruitment.\",\n      \"evidence\": \"ELISA, flow cytometry, RT-PCR, Boyden chamber migration, and blocking antibodies in human adherent monocytes\",\n      \"pmids\": [\"18591415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Signaling intermediates between Fcγ receptor engagement and Mac-1 upregulation not mapped\",\n        \"Contribution of each individual Fcγ receptor isoform not isolated\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple studies in 2011 established that CRP exists in functionally distinct pentameric and monomeric isoforms (mCRP retains C1q binding), that CRP opsonizes secondary necrotic cells to switch macrophage clearance toward pro-inflammatory cytokine production, and that Sirt1 suppresses CRP transcription by deacetylating H4K16 at HNF-1α sites on the CRP promoter under nutrient restriction.\",\n      \"evidence\": \"Aptamer-based isoform discrimination with C1q binding (mCRP); macrophage phagocytosis assay with CRP-opsonized SNEC (clearance); Co-IP, ChIP, and pharmacological Sirt1 inhibition in primary hepatocytes (transcription)\",\n      \"pmids\": [\"21725632\", \"22566859\", \"21176092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo sites and triggers of pentamer-to-monomer conversion not defined\",\n        \"Relative contribution of Sirt1 versus other HNF-1α co-regulators in human hepatocytes not established\",\n        \"Receptor(s) mediating mCRP-specific pro-inflammatory signaling unidentified\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that CRP induces GDF15 expression through p53 recruitment to the GDF15 promoter in aortic endothelial cells linked CRP to a defined transcriptional output in the vasculature.\",\n      \"evidence\": \"CRP treatment and plasmid transfection in HAECs, dual-luciferase reporter and ChIP assays for p53 at GDF15 promoter\",\n      \"pmids\": [\"29967567\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Upstream mechanism by which CRP activates p53 not determined\",\n        \"Functional consequence of CRP-induced GDF15 on vascular biology not shown\",\n        \"Single study without independent replication\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Pharmacological dissection using ruxolitinib and tocilizumab in human primary hepatocytes definitively placed IL-6/JAK/STAT as the dominant signaling axis for CRP induction, while a parallel study showed that HIF-1α competes with AHR for ARNT binding to modulate CRP transcription in arthritis, adding an alternative transcriptional regulatory node.\",\n      \"evidence\": \"Ruxolitinib/tocilizumab in primary hepatocytes and HepaRG cells (JAK/STAT); hepatocyte-specific HIF-1α deletion and Co-IP of AHR-ARNT in arthritic rats (HIF-1α/AHR)\",\n      \"pmids\": [\"31654094\", \"31594926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Integration of JAK/STAT, HNF-1α/Sirt1, and AHR/HIF-1α pathways in a unified transcriptional model not achieved\",\n        \"Whether HIF-1α/AHR competition operates in human hepatocytes not confirmed\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"CRP activates ERK, AKT, and STAT3 in pancreatic neuroendocrine neoplasm cells and induces IL-6 secretion and invasion independently of classical Fcγ receptors, suggesting additional CRP uptake mechanisms in non-immune cells.\",\n      \"evidence\": \"ELISA, Western blot, flow cytometry, and invasion assays in BON1 cells lacking CD16/CD32/CD64\",\n      \"pmids\": [\"31234146\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Alternative receptor or uptake mechanism for CRP in Fcγ receptor-negative cells not identified\",\n        \"In vivo relevance to neuroendocrine tumor progression not established\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for CRP–Fcγ receptor and CRP–C1q interactions, the physiological triggers and sites of pentamer-to-monomer conversion in vivo, integration of the multiple transcriptional regulatory inputs (IL-6/JAK/STAT, HNF-1α/Sirt1, AHR/ARNT/HIF-1α) into a unified model, and the identity of the CRP receptor(s) on Fcγ-negative cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No co-crystal structure of CRP with C1q or any Fcγ receptor\",\n        \"In vivo mechanism and kinetics of mCRP generation unknown\",\n        \"Receptor mediating CRP effects in Fcγ receptor-negative cells unidentified\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [7, 9, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 10, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 3, 6, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 7, 9, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 15, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [12, 16, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"C1Q\",\n      \"FCGR2A\",\n      \"FCGR2B\",\n      \"FCGR1A\",\n      \"SIRT1\",\n      \"HNF1A\",\n      \"ITGAM\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}